OverviewSuggest Edit

Prokarium is a company that develops a microbial genetics product designed for targeted vaccines and cancer immunotherapies. The company's product generates broad immune responses including mucosal, systemic and cellular immunity for the treatment of solid tumors as well as other oral vaccines, enabling doctors to evaluate the safety and immunogenicity of the bivalent vaccine.
HQLondon, GB


Prokarium is headquartered in
London, United Kingdom

Location Map

Latest Updates

Employees (est.) (Feb 2020)21(+5%)

Key People/Management at Prokarium

Ted Fjällman

Ted Fjällman

Kristen Albright

Kristen Albright

VP BD & Translational Research
Mike Darsley

Mike Darsley

Head of Clinical Development
Paola Salerno

Paola Salerno

Head of Molecular Biology
Show more

Prokarium Office Locations

Prokarium has an office in London
London, GB (HQ)
2 Royal College St
Show all (1)

Prokarium Financials and Metrics

Summary Metrics

Founding Date


Prokarium total Funding

$26.6 m

Prokarium latest funding size

$5.66 m

Time since last funding

4 months ago

Prokarium investors

Prokarium's latest funding round in October 2019 was reported to be $5.7 m. In total, Prokarium has raised $26.6 m
Show all financial metrics

Prokarium Online and Social Media Presence

Embed Graph

Prokarium Frequently Asked Questions

  • When was Prokarium founded?

    Prokarium was founded in 2012.

  • Who are Prokarium key executives?

    Prokarium's key executives are Ted Fjällman, Kristen Albright and Mike Darsley.

  • How many employees does Prokarium have?

    Prokarium has 21 employees.

  • Who are Prokarium competitors?

    Competitors of Prokarium include Cytoseek, Arranta Bio and Lucence.

  • Where is Prokarium headquarters?

    Prokarium headquarters is located at 2 Royal College St, London.

  • Where are Prokarium offices?

    Prokarium has an office in London.

  • How many offices does Prokarium have?

    Prokarium has 1 office.